October 01, 2026 at 10:02 AM UTC
Sagimet Biosciences Inc. reports material agreement in SEC 8-K
Sagimet Biosciences Inc. filed an 8-K covering a material definitive agreement. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: September 30, 2026 at 10:00 PM UTC
Open official source